Download PTU M-Pharma 2019 May 2nd Semester 74937 REGULATORY ASPECTS OF DRUGS and COSMETICS Question Paper

Roll No.

Total No. of Questions : 06

Total No. of Pages : 02

--- Content provided by⁠ FirstRanker.com ---

M.Pharmacy(Regulatory Affairs) (2017 Batch) (Sem.-2)

REGULATORY ASPECTS OF DRUGS & COSMETICS

Subject Code : MRA-201T

M.Code: 74937

Time: 3 Hrs.

--- Content provided by‍ FirstRanker.com ---

Max. Marks : 75

INSTRUCTIONS TO CANDIDATES :

1. Attempt any FIVE questions out of SIX questions.
2. Each question carries FIFTEEN marks.

Q1. a) Discuss the regulation approval process for NDA. (8)

--- Content provided by FirstRanker.com ---

b) Explain the regulatory consideration for packaging and labeling of pharmaceutical in EU. (7)

Q2. a) Write the full form of the following : (6)

1. CFR
2. DMF
3. CIS

--- Content provided by​ FirstRanker.com ---

4. ANDA
5. ASEAN
6. FFDCA

b) Discuss the regulatory requirement for manufacturing of pharmaceuticals in EU. (9)

Q3. Write a note on Any Three : (5×3)

--- Content provided by‍ FirstRanker.com ---

1. CFR
2. WHO in relation to registration
3. ANDA
4. Labeling of pharmaceuticals in Japan

Q4. Discuss in detail the organization and structure of EMA. Also discuss one marketing authorization procedure in EU. (15)

--- Content provided by‍ FirstRanker.com ---

Q5. Explain the following is relation of Hatch Waxman act. (5×3)

1. 30 month stay
2. NCE exclusivity
3. Discuss the import of cosmetic in ASEAN countries.

Q6. a) What are the regulatory considerations for manufacturing in Japan? (7.5×2)

--- Content provided by FirstRanker.com ---

b) Write a detailed note on DMF.

NOTE : Disclosure of Identity by writing Mobile No. or Making of passing request on any page of Answer Sheet will lead to UMC against the Student.

Get Previous Year Question Papers at FirstRanker.com